Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.1925
-0.0025 (-1.28%)
May 6, 2026, 4:26 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 8.37 million as of May 6, 2026. Its market cap has decreased by -5.02% in one year.
Market Cap
8.37M
Enterprise Value
12.09M
Revenue
1.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 8.37M, a decrease of -93.89%. That is a compound annual growth rate of -25.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 8.37M | -9.30% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 20.73M |
| Genflow Biosciences | 15.86M |
| Fusion Antibodies | 15.63M |
| IXICO | 14.99M |
| Cizzle Biotechnology Holdings | 10.31M |
| CRISM Therapeutics | 6.47M |
| OptiBiotix Health | 5.27M |
| Thalia Therapeutics | 4.79M |